Decoding the immune regulation of ovarian aging: mechanisms and therapeutic strategies

免疫衰老 免疫系统 卵巢早衰 免疫学 生殖免疫学 卵巢储备 生物 细胞因子 炎症 免疫失调 免疫 先天免疫系统 医学 生物信息学 获得性免疫系统 自身免疫 免疫耐受 串扰 安非雷古林 平衡 胸腺退化 卵巢早衰 卵泡 长寿
作者
Changjing Wang,Nianyu Li,Zi‐Jiang Chen,Yingying Qin,Xue Jiao
出处
期刊:Human Reproduction Update [Oxford University Press]
标识
DOI:10.1093/humupd/dmag030
摘要

BACKGROUND: Ovarian aging is among the earliest functional declines in humans and acts as a pacemaker of female aging. It encompasses both physiological age-related ovarian decline and pathological accelerated aging, exemplified by premature ovarian insufficiency (POI). Increasing evidence positions the immune system as both a regulator of ovarian homeostasis and a driver of ovarian dysfunction. Age-related immunosenescence and chronic low-grade inflammation (inflammaging) coordinately drive ovarian aging through bidirectional crosstalk between systemic immunity and the ovarian immune microenvironment. POI frequently coexists with autoimmune disorders, reinforcing the central role of the immune-ovarian axis in reproductive aging. Elucidating this interplay may enable targeted immunomodulatory strategies to preserve reproductive longevity and mitigate systemic consequences of ovarian decline. OBJECTIVE AND RATIONALE: The aim was to synthesize current evidence on (i) immune regulation of normal ovarian physiology; (ii) immune alterations in physiological ovarian aging, including systemic immunosenescence and ovarian immune microenvironment remodelling; (iii) autoimmune dysregulation in POI; and (iv) the translational potential of immunomodulatory interventions for mitigating ovarian aging. SEARCH METHODS: Original articles published up to April 2026 were identified through PubMed using combinations of the terms 'immune system', 'ovarian function', 'inflammation', 'immune cell', 'ovarian aging', 'menopause', 'primary ovarian insufficiency', and 'therapeutics'. OUTCOMES: Immune cells and cytokine networks form a specialized regulatory axis that governs folliculogenesis, ovulation, and luteal dynamics. This review synthesizes emerging evidence showing that this immune-ovary axis undergoes profound remodelling during reproductive aging and that immune dysregulation is a causal driver of ovarian functional decline. Systemically, the menopausal transition accelerates immunosenescence and amplifies pro-inflammatory cytokine production. Locally, the aging ovary exhibits chronic inflammation, NLRP3 inflammasome activation, and accumulation of senescent cells with a senescence‑associated secretory phenotype. These changes coincide with a shift from tissue‑resident to monocyte‑derived macrophages and expansion of inflammatory γδ and double‑negative T cells. This progressive loss of immune homeostasis promotes follicular depletion, stromal fibrosis, and impaired steroidogenesis. POI represents a pathological extreme of this axis, characterized by autoimmune comorbidities, B cell-driven humoural abnormalities, T cell dysregulation, and genetic variants affecting immune pathways. Comparative analysis reveals both conserved inflammatory signatures shared with physiological aging and POI-specific immune features that reflect overt immune-mediated ovarian injury. By integrating systemic, local, and disease-specific immune mechanisms, this review reframes ovarian aging as a modifiable immunological process. Therapeutically, emerging immunomodulatory strategies range from molecular agents targeting inflammatory mediators and senescence programs, through cell-based immune reprogramming with stem cells, regulatory T cells, and senolytic immune effectors, to lifestyle-driven systemic immunomodulation. These strategies show promise in restoring ovarian immune homeostasis and extending the reproductive lifespan, with several of these approaches now advancing toward early-phase clinical evaluation. WIDER IMPLICATIONS: Collectively, the current evidence positions immune dysregulation as a mechanistic driver, rather than a secondary correlate, of ovarian aging. Integrating immune biomarkers into predictive frameworks and designing stratified immunomodulatory trials may shift ovarian aging management from symptomatic hormone replacement toward mechanism-based intervention. Reframing ovarian aging as a modifiable immune-mediated process offers new opportunities to extend female reproductive longevity and the female health span. REGISTRATION NUMBER: N/A.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Lionel_Art完成签到,获得积分10
刚刚
刚刚
刚刚
lsq发布了新的文献求助10
刚刚
科研通AI6.4的应助被chi采纳,获得10
1秒前
4秒前
TCM-DH发布了新的文献求助10
4秒前
顾矜的应助被现代的随阴采纳,获得10
6秒前
6秒前
6秒前
selena发布了新的文献求助10
7秒前
HaidongZhang发布了新的文献求助10
7秒前
慕青的应助被马秀玲采纳,获得10
9秒前
10秒前
11秒前
Elmore发布了新的文献求助10
11秒前
演员发布了新的文献求助10
12秒前
英俊的铭的应助被Kaitlyn采纳,获得10
12秒前
李健的粉丝团团长的应助被ghj采纳,获得10
13秒前
jackson_WANG发布了新的文献求助10
13秒前
顺利张完成签到,获得积分10
14秒前
万梓文祥完成签到 ,获得积分10
16秒前
bkagyin的应助被热情的远锋采纳,获得10
17秒前
杨庄鸡块发布了新的文献求助10
17秒前
17秒前
kary完成签到,获得积分10
18秒前
18秒前
19秒前
万能图书馆的应助被混元灵通采纳,获得10
20秒前
20秒前
molihuakai的应助被韩明佐采纳,获得10
20秒前
阿刁完成签到,获得积分10
20秒前
852的应助被TEDDY采纳,获得20
21秒前
jackson_WANG完成签到,获得积分10
21秒前
在水一方的应助被imfangyu采纳,获得10
22秒前
22秒前
马秀玲发布了新的文献求助10
24秒前
24秒前
24秒前
Flora发布了新的文献求助10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183263
求助须知:如何正确求助?哪些是违规求助? 9572532
关于积分的说明 21826339
捐赠科研通 7780187
什么是DOI,文献DOI怎么找? 3433993
关于科研通互助平台的介绍 2558131
邀请新用户注册赠送积分活动 2480239